← Open Payments lookup

IVAN SPECTOR: Open Payments

NPI 1124207279 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,312 in 56 payments from 13 companies in 2025. Trend: 2023 $1,341 · 2024 $1,794 · 2025 $1,312

Food & beverage: $1,312
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$199
Lundbeck LLC7$182
Teva Pharmaceuticals USA, Inc.6$149
ABBVIE INC.7$142
Otsuka America Pharmaceutical, Inc.5$122
Alkermes, Inc.4$114
Takeda Pharmaceuticals U.S.A., Inc.5$101
Neurocrine BioSciences, Inc.4$92
E.R. Squibb & Sons, L.L.C.3$85
Almatica Pharma LLC2$56

Products named: REXULTI, CAPLYTA, VRAYLAR, ARISTADA, TRINTELLIX, UZEDY, INGREZZA, COBENFY.

Industry payments across TX — which companies pay providers there.